Malenka Robert C.

SEC Form 4 insider trading activity

Malenka Robert C. has filed 7 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Apr 17, 2026.

On the most recent filing, Malenka Robert C. is listed as Director at MapLight Therapeutics, Inc. Inside the rolling window, Malenka Robert C. reported no open-market purchases and 12 open-market sales totaling $1.6M in MPLT. The largest disclosed transaction in the window is a sale of 21,262 MPLT shares on Jan 29, 2026, worth $394K.

Companies traded

Other insiders at MPLT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.6M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MPLTSale$231KApr 17SEC ↗
MPLTSale$40KFeb 24SEC ↗
MPLTSale$207KFeb 24SEC ↗
MPLTSale$13KFeb 24SEC ↗
MPLTSale$221KFeb 18SEC ↗
MPLTSale$120KFeb 12SEC ↗
MPLTSale$4KFeb 12SEC ↗
MPLTSale$127KFeb 4SEC ↗
MPLTSale$18Feb 4SEC ↗
MPLTSale$122KJan 30SEC ↗
MPLTSale$394KJan 30SEC ↗
MPLTSale$120KJan 30SEC ↗
Showing 1–12 of 12
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Malenka Robert C. made?

Malenka Robert C. has filed 7 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.

Which companies does Malenka Robert C. trade?

Malenka Robert C. has filed SEC Form 4 disclosures for 1 company, including MPLT.

When was Malenka Robert C.'s most recent SEC Form 4 filing?

Malenka Robert C.'s most recent SEC Form 4 filing on Tracefour is dated Apr 17, 2026.

What is Malenka Robert C.'s total buy and sell value in the current window?

Inside the rolling retention window, Malenka Robert C. bought $0 and sold $1.6M based on SEC Form 4 filings.

What was Malenka Robert C.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 21,262 MPLT shares on 2026-01-29, worth $394K, per SEC Form 4 filings.